Do commonly used prostate medications alter prostate MRI and fusion biopsy performance?

2021 ◽  
Author(s):  
Kevin Krughoff ◽  
Dylan M. Buller ◽  
Shuo-Chieh Wu ◽  
Roberto Rodriguez ◽  
Amichai Kilchevsky ◽  
...  
Keyword(s):  
Fusion Biopsy ◽  
Prostate Mri

Prostate MRI–TRUS fusion biopsy: a review of the state of the art procedure

2020 ◽  
Vol 45 (7) ◽  
pp. 2176-2183 ◽  
Author(s):  
Chandan J. Das ◽  
Abdul Razik ◽  
Arjunlokesh Netaji ◽  
Sadhna Verma
Keyword(s):  
State Of The Art ◽  
The State ◽  
Fusion Biopsy ◽  
Prostate Mri

scholarly journals Prostate MRI and transperineal TRUS/MRI fusion biopsy for prostate cancer detection: clinical practice updates

2019 ◽  
Vol 45 (4) ◽  
pp. 237-244
Author(s):  
Eugenio Martorana ◽  
◽  
Giacomo Maria Pirola ◽  
Maria Cristina Aisa ◽  
Pietro Scialpi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Practice ◽  
Cancer Detection ◽  
Fusion Biopsy ◽  
Prostate Mri ◽  
Prostate Cancer Detection

The learning curve of prostate MRI/TRUS target fusion biopsy after more than 1000 procedures: Residents’ experience

2021 ◽  
Vol 79 ◽  
pp. S1352
Author(s):  
E. Checcucci ◽  
F. Piramide ◽  
S. De Cillis ◽  
D. Amparore ◽  
G. Volpi ◽  
...  
Keyword(s):  
Learning Curve ◽  
Fusion Biopsy ◽  
Prostate Mri

scholarly journals MP14-18 FOLLOW UP FOR PATIENTS ON ACTIVE SURVEILLANCE FOLLOWING A CONFIRMATORY PROSTATE MRI-FUSION BIOPSY

2018 ◽  
Vol 199 (4S) ◽  
Author(s):  
Jonathan B. Bloom ◽  
Joseph Baiocco ◽  
Sam Gold ◽  
Graham Hale ◽  
Kareem Rayn ◽  
...  
Keyword(s):  
Active Surveillance ◽  
Fusion Biopsy ◽  
Prostate Mri

scholarly journals PD54-11 IMPLEMENTATION OF A STATE-WIDE QUALITY ASSURANCE INITIATIVE FOR PROSTATE MRI AND FUSION BIOPSY

2020 ◽  
Vol 203 ◽  
pp. e1108
Author(s):  
Madison Drye* ◽  
Anna Johnson ◽  
Ji Qi ◽  
Karla Witzke ◽  
Lindsay Zeeb ◽  
...  
Keyword(s):  
Quality Assurance ◽  
Fusion Biopsy ◽  
Prostate Mri

Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey

2020 ◽  
Vol 6 (2) ◽  
pp. 273-279 ◽  
Author(s):  
Laura Bukavina ◽  
Jon C. Tilburt ◽  
Badrinath Konety ◽  
Nilay D. Shah ◽  
Cary P. Gross ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
National Survey ◽  
Fusion Biopsy ◽  
Prostate Mri ◽  
Radiation Oncologists

PD12-02 MULTIPARAMETRIC PROSTATE MRI AND MRI/ULTRASOUND FUSION BIOPSY IN THE FOLLOW-UP OF PROSTATE CANCER PROGRESSION FOR MEN ON ACTIVE SURVEILLANCE

2014 ◽  
Vol 191 (4S) ◽  
Author(s):  
Annerleim Walton-Diaz ◽  
Nabeel Shakir ◽  
Soroush Rais-Bahrami ◽  
Baris Turkbey ◽  
Jason Rothwax ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Active Surveillance ◽  
Cancer Progression ◽  
Prostate Cancer Progression ◽  
Fusion Biopsy ◽  
Prostate Mri ◽  
Multiparametric Prostate Mri

scholarly journals Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies

Cancer ◽  
2016 ◽  
Vol 122 (6) ◽  
pp. 884-892 ◽  
Author(s):  
Christopher P. Filson ◽  
Shyam Natarajan ◽  
Daniel J.A. Margolis ◽  
Jiaoti Huang ◽  
Patricia Lieu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Magnetic Resonance ◽  
Cancer Detection ◽  
Fusion Biopsy ◽  
Prostate Cancer Detection ◽  
Targeted Biopsies

Naive patients with suspicious prostate cancer and positive multiparametric magnetic resonance imaging (mp-MRI): is it time for fusion target biopsy alone?

2021 ◽  
pp. 205141582110237
Author(s):  
Enrico Checcucci ◽  
Sabrina De Cillis ◽  
Daniele Amparore ◽  
Diletta Garrou ◽  
Roberta Aimar ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Prostate Cancer ◽  
Magnetic Resonance ◽  
Detection Rate ◽  
Resonance Imaging ◽  
Fusion Biopsy ◽  
Grade Group ◽  
Final Pathology ◽  
Multiparametric Magnetic Resonance Imaging ◽  
Clinically Significant

Objectives: To determine if standard biopsy still has a role in the detection of prostate cancer or clinically significant prostate cancer in biopsy-naive patients with positive multiparametric magnetic resonance imaging. Materials and methods: We extracted, from our prospective maintained fusion biopsy database, patients from March 2014 to December 2018. The detection rate of prostate cancer and clinically significant prostate cancer and complication rate were analysed in a cohort of patients who underwent fusion biopsy alone (group A) or fusion biopsy plus standard biopsy (group B). The International Society of Urological Pathology grade group determined on prostate biopsy with the grade group determined on final pathology among patients who underwent radical prostatectomy were compared. Results: Prostate cancer was found in 249/389 (64.01%) and 215/337 (63.8%) patients in groups A and B, respectively ( P=0.98), while the clinically significant prostate cancer detection rate was 57.8% and 55.1% ( P=0.52). No significant differences in complications were found. No differences in the upgrading rate between biopsy and final pathology finding after radical prostatectomy were recorded. Conclusions: In biopsy-naive patients, with suspected prostate cancer and positive multiparametric magnetic resonance imaging the addition of standard biopsy to fusion biopsy did not increase significantly the detection rate of prostate cancer or clinically significant prostate cancer. Moreover, the rate of upgrading of the cancer grade group between biopsy and final pathology was not affected by the addition of standard biopsy. Level of evidence: Not applicable for this multicentre audit.

Sign in / Sign up

Export Citation Format

Share Document